<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   597
  </number>
  <updateDate>
   2023-01-11T13:43:24Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:43:24Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-01-28
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 17 (Thursday, January 28, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. SCHAKOWSKY:H.R. 597.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3The Congress shall have Power . . . To regulate Commercewith foreign Nations, and among the several States, and withthe Indian Tribes.[Page H252]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsju00
    </systemCode>
    <name>
     Judiciary Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsju03
      </systemCode>
      <name>
       Courts, Intellectual Property, and the Internet Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-03-22T15:38:19Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-28T14:07:50Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-02T16:17:08Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-28T14:07:45Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsas00
    </systemCode>
    <name>
     Armed Services Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-28T14:08:05Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hssy00
    </systemCode>
    <name>
     Science, Space, and Technology Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-01-28T14:08:00Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-03-22
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsju03
      </systemCode>
      <name>
       Courts, Intellectual Property, and the Internet Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-01-28
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsas00
      </systemCode>
      <name>
       Armed Services Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-28
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hssy00
      </systemCode>
      <name>
       Science, Space, and Technology Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-28
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-28
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-01-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-01-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     S001145
    </bioguideId>
    <fullName>
     Rep. Schakowsky, Janice D. [D-IL-9]
    </fullName>
    <firstName>
     JANICE
    </firstName>
    <lastName>
     SCHAKOWSKY
    </lastName>
    <party>
     D
    </party>
    <state>
     IL
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     9
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     D000399
    </bioguideId>
    <fullName>
     Rep. Doggett, Lloyd [D-TX-35]
    </fullName>
    <firstName>
     LLOYD
    </firstName>
    <lastName>
     DOGGETT
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     35
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000216
    </bioguideId>
    <fullName>
     Rep. DeLauro, Rosa L. [D-CT-3]
    </fullName>
    <firstName>
     ROSA
    </firstName>
    <lastName>
     DELAURO
    </lastName>
    <party>
     D
    </party>
    <state>
     CT
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000191
    </bioguideId>
    <fullName>
     Rep. DeFazio, Peter A. [D-OR-4]
    </fullName>
    <firstName>
     PETER
    </firstName>
    <lastName>
     DEFAZIO
    </lastName>
    <party>
     D
    </party>
    <state>
     OR
    </state>
    <middleName>
     A.
    </middleName>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000551
    </bioguideId>
    <fullName>
     Rep. Grijalva, Raúl M. [D-AZ-3]
    </fullName>
    <firstName>
     Raúl
    </firstName>
    <lastName>
     Grijalva
    </lastName>
    <party>
     D
    </party>
    <state>
     AZ
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000389
    </bioguideId>
    <fullName>
     Rep. Khanna, Ro [D-CA-17]
    </fullName>
    <firstName>
     Ro
    </firstName>
    <lastName>
     Khanna
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     R000606
    </bioguideId>
    <fullName>
     Rep. Raskin, Jamie [D-MD-8]
    </fullName>
    <firstName>
     Jamie
    </firstName>
    <lastName>
     Raskin
    </lastName>
    <party>
     D
    </party>
    <state>
     MD
    </state>
    <district>
     8
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000597
    </bioguideId>
    <fullName>
     Rep. Pingree, Chellie [D-ME-1]
    </fullName>
    <firstName>
     Chellie
    </firstName>
    <lastName>
     Pingree
    </lastName>
    <party>
     D
    </party>
    <state>
     ME
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000800
    </bioguideId>
    <fullName>
     Rep. Welch, Peter [D-VT-At Large]
    </fullName>
    <firstName>
     Peter
    </firstName>
    <lastName>
     Welch
    </lastName>
    <party>
     D
    </party>
    <state>
     VT
    </state>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000607
    </bioguideId>
    <fullName>
     Rep. Pocan, Mark [D-WI-2]
    </fullName>
    <firstName>
     Mark
    </firstName>
    <lastName>
     Pocan
    </lastName>
    <party>
     D
    </party>
    <state>
     WI
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B000490
    </bioguideId>
    <fullName>
     Rep. Bishop, Sanford D., Jr. [D-GA-2]
    </fullName>
    <firstName>
     SANFORD
    </firstName>
    <lastName>
     BISHOP
    </lastName>
    <party>
     D
    </party>
    <state>
     GA
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000147
    </bioguideId>
    <fullName>
     Del. Norton, Eleanor Holmes [D-DC-At Large]
    </fullName>
    <firstName>
     ELEANOR
    </firstName>
    <lastName>
     NORTON
    </lastName>
    <party>
     D
    </party>
    <state>
     DC
    </state>
    <middleName>
     HOLMES
    </middleName>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001143
    </bioguideId>
    <fullName>
     Rep. McCollum, Betty [D-MN-4]
    </fullName>
    <firstName>
     BETTY
    </firstName>
    <lastName>
     MCCOLLUM
    </lastName>
    <party>
     D
    </party>
    <state>
     MN
    </state>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000298
    </bioguideId>
    <fullName>
     Rep. Jayapal, Pramila [D-WA-7]
    </fullName>
    <firstName>
     Pramila
    </firstName>
    <lastName>
     Jayapal
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001080
    </bioguideId>
    <fullName>
     Rep. Chu, Judy [D-CA-27]
    </fullName>
    <firstName>
     Judy
    </firstName>
    <lastName>
     Chu
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     27
    </district>
    <sponsorshipDate>
     2021-01-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001204
    </bioguideId>
    <fullName>
     Del. San Nicolas, Michael F. Q. [D-GU-At Large]
    </fullName>
    <firstName>
     Michael
    </firstName>
    <lastName>
     San Nicolas
    </lastName>
    <party>
     D
    </party>
    <state>
     GU
    </state>
    <middleName>
     F. Q.
    </middleName>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-02-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001072
    </bioguideId>
    <fullName>
     Rep. Carson, Andre [D-IN-7]
    </fullName>
    <firstName>
     Andre
    </firstName>
    <lastName>
     Carson
    </lastName>
    <party>
     D
    </party>
    <state>
     IN
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-02-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     E000296
    </bioguideId>
    <fullName>
     Rep. Evans, Dwight [D-PA-3]
    </fullName>
    <firstName>
     Dwight
    </firstName>
    <lastName>
     Evans
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-02-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     H000324
    </bioguideId>
    <fullName>
     Rep. Hastings, Alcee L. [D-FL-20]
    </fullName>
    <firstName>
     ALCEE
    </firstName>
    <lastName>
     HASTINGS
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     L.
    </middleName>
    <district>
     20
    </district>
    <sponsorshipDate>
     2021-02-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000623
    </bioguideId>
    <fullName>
     Rep. DeSaulnier, Mark [D-CA-11]
    </fullName>
    <firstName>
     Mark
    </firstName>
    <lastName>
     DeSaulnier
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     11
    </district>
    <sponsorshipDate>
     2021-02-22
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001205
    </bioguideId>
    <fullName>
     Rep. Scanlon, Mary Gay [D-PA-5]
    </fullName>
    <firstName>
     Mary
    </firstName>
    <lastName>
     Scanlon
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <middleName>
     Gay
    </middleName>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-02-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000468
    </bioguideId>
    <fullName>
     Rep. Titus, Dina [D-NV-1]
    </fullName>
    <firstName>
     Dina
    </firstName>
    <lastName>
     Titus
    </lastName>
    <party>
     D
    </party>
    <state>
     NV
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-02-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     L000586
    </bioguideId>
    <fullName>
     Rep. Lawson, Al, Jr. [D-FL-5]
    </fullName>
    <firstName>
     Al
    </firstName>
    <lastName>
     Lawson
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-02-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001068
    </bioguideId>
    <fullName>
     Rep. Cohen, Steve [D-TN-9]
    </fullName>
    <firstName>
     Steve
    </firstName>
    <lastName>
     Cohen
    </lastName>
    <party>
     D
    </party>
    <state>
     TN
    </state>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     H001081
    </bioguideId>
    <fullName>
     Rep. Hayes, Jahana [D-CT-5]
    </fullName>
    <firstName>
     Jahana
    </firstName>
    <lastName>
     Hayes
    </lastName>
    <party>
     D
    </party>
    <state>
     CT
    </state>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000523
    </bioguideId>
    <fullName>
     Rep. Price, David E. [D-NC-4]
    </fullName>
    <firstName>
     DAVID
    </firstName>
    <lastName>
     PRICE
    </lastName>
    <party>
     D
    </party>
    <state>
     NC
    </state>
    <middleName>
     E.
    </middleName>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-05-04
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000193
    </bioguideId>
    <fullName>
     Rep. Thompson, Bennie G. [D-MS-2]
    </fullName>
    <firstName>
     BENNIE
    </firstName>
    <lastName>
     THOMPSON
    </lastName>
    <party>
     D
    </party>
    <state>
     MS
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-05-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Business records
     </name>
    </item>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Civil actions and liability
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Drug therapy
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Fraud offenses and financial crimes
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Health programs administration and funding
     </name>
    </item>
    <item>
     <name>
      Health promotion and preventive care
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Immunology and vaccination
     </name>
    </item>
    <item>
     <name>
      Income tax credits
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Inflation and prices
     </name>
    </item>
    <item>
     <name>
      Intellectual property
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      Minority health
     </name>
    </item>
    <item>
     <name>
      Public contracts and procurement
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
    <item>
     <name>
      User charges and fees
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-01-28
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-03-09T00:15:42Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt; Pandemic Treatment Access and Affordability Act of 2021 &lt;/b&gt;&lt;/p&gt; &lt;p class="MsoNormal" style="line-height: normal;"&gt;This bill imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies.&lt;/p&gt; &lt;p class="MsoNormal" style="line-height: normal;"&gt;With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or assignee for such a patent shall grant open nonexclusive licenses for the patent. An entity that receives a license shall pay reasonable royalties to (1) the patent holder, or (2) the owner of marketing exclusivity rights granted by the Food and Drug Administration (FDA) that were terminated under this bill. &lt;/p&gt; &lt;p class="MsoNormal" style="line-height: normal;"&gt;The bill requires that such drugs be offered at a fair and reasonable price based on certain considerations, such as access. &lt;/p&gt; &lt;p class="MsoNormal" style="line-height: normal;"&gt;If the Department of Health and Human Services (HHS) finds that the price of any drug to address a public health emergency is excessive, HHS must void any FDA-granted exclusivity for the drug and grant open and nonexclusive licenses to other manufacturers. Such licenses are subject to reasonable royalty requirements.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Pandemic Treatment Access and Affordability Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Pandemic Treatment Access and Affordability Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Pandemic Treatment Access and Affordability Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-01-28T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr597ih/xml/BILLS-117hr597ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-03-22
   </actionDate>
   <text>
    Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-03-22
Courts, Intellectual Property, and the Internet Subcommittee
hsju03
1
House committee actions
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Committee
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-28
Armed Services Committee
hsas00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-01-28
Science, Space, and Technology Committee
hssy00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-01-28
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-01-28
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-01-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-28
9
Library of Congress
Introduced in House
IntroReferral
2021-01-28T14:07:50Z
Referred to
House
Judiciary Committee
2021-03-22T15:38:19Z
Referred to
Courts, Intellectual Property, and the Internet Subcommittee
hsju03
hsju00
Standing
2021-01-28T14:07:45Z
Referred to
House
Energy and Commerce Committee
2021-02-02T16:17:08Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-01-28T14:08:05Z
Referred to
House
Armed Services Committee
hsas00
Standing
2021-01-28T14:08:00Z
Referred to
House
Science, Space, and Technology Committee
hssy00
Standing
D000399
35
LLOYD
Rep. Doggett, Lloyd [D-TX-35]
DOGGETT
D
2021-01-28
TX
D000216
3
ROSA
Rep. DeLauro, Rosa L. [D-CT-3]
DELAURO
D
2021-01-28
CT
D000191
4
PETER
Rep. DeFazio, Peter A. [D-OR-4]
DEFAZIO
A.
D
2021-01-28
OR
G000551
3
Raúl
Rep. Grijalva, Raúl M. [D-AZ-3]
Grijalva
M.
D
2021-01-28
AZ
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2021-01-28
CA
R000606
8
Jamie
Rep. Raskin, Jamie [D-MD-8]
Raskin
D
2021-01-28
MD
P000597
1
Chellie
Rep. Pingree, Chellie [D-ME-1]
Pingree
D
2021-01-28
ME
W000800
0
Peter
Rep. Welch, Peter [D-VT-At Large]
Welch
D
2021-01-28
VT
P000607
2
Mark
Rep. Pocan, Mark [D-WI-2]
Pocan
D
2021-01-28
WI
B000490
2
SANFORD
Rep. Bishop, Sanford D., Jr. [D-GA-2]
BISHOP
D.
D
2021-01-28
GA
N000147
0
ELEANOR
Del. Norton, Eleanor Holmes [D-DC-At Large]
NORTON
HOLMES
D
2021-01-28
DC
M001143
4
BETTY
Rep. McCollum, Betty [D-MN-4]
MCCOLLUM
D
2021-01-28
MN
J000298
7
Pramila
Rep. Jayapal, Pramila [D-WA-7]
Jayapal
D
2021-01-28
WA
C001080
27
Judy
Rep. Chu, Judy [D-CA-27]
Chu
D
2021-01-28
CA
S001204
0
Michael
Del. San Nicolas, Michael F. Q. [D-GU-At Large]
San Nicolas
F. Q.
D
2021-02-22
GU
C001072
7
Andre
Rep. Carson, Andre [D-IN-7]
Carson
D
2021-02-22
IN
E000296
3
Dwight
Rep. Evans, Dwight [D-PA-3]
Evans
D
2021-02-22
PA
H000324
20
ALCEE
Rep. Hastings, Alcee L. [D-FL-20]
HASTINGS
L.
D
2021-02-22
FL
D000623
11
Mark
Rep. DeSaulnier, Mark [D-CA-11]
DeSaulnier
D
2021-02-22
CA
S001205
5
Mary
Rep. Scanlon, Mary Gay [D-PA-5]
Scanlon
Gay
D
2021-02-23
PA
T000468
1
Dina
Rep. Titus, Dina [D-NV-1]
Titus
D
2021-02-23
NV
L000586
5
Al
Rep. Lawson, Al, Jr. [D-FL-5]
Lawson
D
2021-02-23
FL
C001068
9
Steve
Rep. Cohen, Steve [D-TN-9]
Cohen
D
2021-03-26
TN
H001081
5
Jahana
Rep. Hayes, Jahana [D-CT-5]
Hayes
D
2021-03-26
CT
P000523
4
DAVID
Rep. Price, David E. [D-NC-4]
PRICE
E.
D
2021-05-04
NC
T000193
2
BENNIE
Rep. Thompson, Bennie G. [D-MS-2]
THOMPSON
D
2021-05-28
MS
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-01-28
2021-03-22
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
House
Health
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
N
SCHAKOWSKY
D.
D
IL
Business records Cardiovascular and respiratory health Civil actions and liability Drug safety, medical device, and laboratory regulation Drug therapy Emergency medical services and trauma care Fraud offenses and financial crimes Government information and archives Health care costs and insurance Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Income tax credits Infectious and parasitic diseases Inflation and prices Intellectual property Manufacturing Medical tests and diagnostic methods Minority health Public contracts and procurement Research and development User charges and fees
2021-01-28
Introduced in House
 <p><b> Pandemic Treatment Access and Affordability Act of 2021 </b></p> <p class="MsoNormal" style="line-height: normal;">This bill imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies.</p> <p class="MsoNormal" style="line-height: normal;">With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or assignee for such a patent shall grant open nonexclusive licenses for the patent. An entity that receives a license shall pay reasonable royalties to (1) the patent holder, or (2) the owner of marketing exclusivity rights granted by the Food and Drug Administration (FDA) that were terminated under this bill. </p> <p class="MsoNormal" style="line-height: normal;">The bill requires that such drugs be offered at a fair and reasonable price based on certain considerations, such as access. </p> <p class="MsoNormal" style="line-height: normal;">If the Department of Health and Human Services (HHS) finds that the price of any drug to address a public health emergency is excessive, HHS must void any FDA-granted exclusivity for the drug and grant open and nonexclusive licenses to other manufacturers. Such licenses are subject to reasonable royalty requirements.</p>
2021-03-09T00:15:42Z
00
2021-01-28T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr597ih/xml/BILLS-117hr597ih.xml
Pandemic Treatment Access and Affordability Act of 2021
Pandemic Treatment Access and Affordability Act of 2021
Display Title
IH
Introduced in House
To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Pandemic Treatment Access and Affordability Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:43:24Z
2023-01-11T13:43:24Z
3.0.0
2021-03-22
Courts, Intellectual Property, and the Internet Subcommittee
hsju03
1
House committee actions
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Committee
2021-02-02
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-01-28
Armed Services Committee
hsas00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-01-28
Science, Space, and Technology Committee
hssy00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-01-28
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-01-28
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-01-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-01-28
9
Library of Congress
Introduced in House
IntroReferral
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
N
SCHAKOWSKY
D.
D
IL
D000399
35
LLOYD
Rep. Doggett, Lloyd [D-TX-35]
DOGGETT
D
2021-01-28
TX
D000216
3
ROSA
Rep. DeLauro, Rosa L. [D-CT-3]
DELAURO
D
2021-01-28
CT
D000191
4
PETER
Rep. DeFazio, Peter A. [D-OR-4]
DEFAZIO
A.
D
2021-01-28
OR
G000551
3
Raúl
Rep. Grijalva, Raúl M. [D-AZ-3]
Grijalva
M.
D
2021-01-28
AZ
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2021-01-28
CA
R000606
8
Jamie
Rep. Raskin, Jamie [D-MD-8]
Raskin
D
2021-01-28
MD
P000597
1
Chellie
Rep. Pingree, Chellie [D-ME-1]
Pingree
D
2021-01-28
ME
W000800
0
Peter
Rep. Welch, Peter [D-VT-At Large]
Welch
D
2021-01-28
VT
P000607
2
Mark
Rep. Pocan, Mark [D-WI-2]
Pocan
D
2021-01-28
WI
B000490
2
SANFORD
Rep. Bishop, Sanford D., Jr. [D-GA-2]
BISHOP
D.
D
2021-01-28
GA
N000147
0
ELEANOR
Del. Norton, Eleanor Holmes [D-DC-At Large]
NORTON
HOLMES
D
2021-01-28
DC
M001143
4
BETTY
Rep. McCollum, Betty [D-MN-4]
MCCOLLUM
D
2021-01-28
MN
J000298
7
Pramila
Rep. Jayapal, Pramila [D-WA-7]
Jayapal
D
2021-01-28
WA
C001080
27
Judy
Rep. Chu, Judy [D-CA-27]
Chu
D
2021-01-28
CA
S001204
0
Michael
Del. San Nicolas, Michael F. Q. [D-GU-At Large]
San Nicolas
F. Q.
D
2021-02-22
GU
C001072
7
Andre
Rep. Carson, Andre [D-IN-7]
Carson
D
2021-02-22
IN
E000296
3
Dwight
Rep. Evans, Dwight [D-PA-3]
Evans
D
2021-02-22
PA
H000324
20
ALCEE
Rep. Hastings, Alcee L. [D-FL-20]
HASTINGS
L.
D
2021-02-22
FL
D000623
11
Mark
Rep. DeSaulnier, Mark [D-CA-11]
DeSaulnier
D
2021-02-22
CA
S001205
5
Mary
Rep. Scanlon, Mary Gay [D-PA-5]
Scanlon
Gay
D
2021-02-23
PA
T000468
1
Dina
Rep. Titus, Dina [D-NV-1]
Titus
D
2021-02-23
NV
L000586
5
Al
Rep. Lawson, Al, Jr. [D-FL-5]
Lawson
D
2021-02-23
FL
C001068
9
Steve
Rep. Cohen, Steve [D-TN-9]
Cohen
D
2021-03-26
TN
H001081
5
Jahana
Rep. Hayes, Jahana [D-CT-5]
Hayes
D
2021-03-26
CT
P000523
4
DAVID
Rep. Price, David E. [D-NC-4]
PRICE
E.
D
2021-05-04
NC
T000193
2
BENNIE
Rep. Thompson, Bennie G. [D-MS-2]
THOMPSON
D
2021-05-28
MS
Business records Cardiovascular and respiratory health Civil actions and liability Drug safety, medical device, and laboratory regulation Drug therapy Emergency medical services and trauma care Fraud offenses and financial crimes Government information and archives Health care costs and insurance Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Income tax credits Infectious and parasitic diseases Inflation and prices Intellectual property Manufacturing Medical tests and diagnostic methods Minority health Public contracts and procurement Research and development User charges and fees
2021-01-28
Introduced in House
 <p><b> Pandemic Treatment Access and Affordability Act of 2021 </b></p> <p class="MsoNormal" style="line-height: normal;">This bill imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies.</p> <p class="MsoNormal" style="line-height: normal;">With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or assignee for such a patent shall grant open nonexclusive licenses for the patent. An entity that receives a license shall pay reasonable royalties to (1) the patent holder, or (2) the owner of marketing exclusivity rights granted by the Food and Drug Administration (FDA) that were terminated under this bill. </p> <p class="MsoNormal" style="line-height: normal;">The bill requires that such drugs be offered at a fair and reasonable price based on certain considerations, such as access. </p> <p class="MsoNormal" style="line-height: normal;">If the Department of Health and Human Services (HHS) finds that the price of any drug to address a public health emergency is excessive, HHS must void any FDA-granted exclusivity for the drug and grant open and nonexclusive licenses to other manufacturers. Such licenses are subject to reasonable royalty requirements.</p>
2021-03-09T00:15:42Z
00
Pandemic Treatment Access and Affordability Act of 2021
Pandemic Treatment Access and Affordability Act of 2021
Display Title
IH
Introduced in House
To require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Pandemic Treatment Access and Affordability Act of 2021
Short Title(s) as Introduced
2021-03-22
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.